The European Commission has announced two acts of GMP legislation: • a directive that sets out principles and guidelines of GMP for medicines where the manufacture or import is subject to a manufacturing authorization (MA), and • a delegated regulation that sets out GMP for investigational medicinal products (IMPs). Member states must transpose the directive into national law by March 31, 2018.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
